Walgreens Boots Alliance (NASDAQ: WBA) reported Q4 EPS of $1.17, $0.16 better than the analyst estimate of $1.01. Revenue for the quarter came in at $34.3 billion versus the consensus estimate of $33.35 billion.

Chief Executive Officer Roz Brewer said, “Our fourth quarter and fiscal year results exceeded expectations, driven by strong performance in our core business. Comparable U.S. pharmacy and retail sales both saw robust growth and recovery continued in our UK business as COVID-19 restrictions eased in the quarter. I remain extremely proud of our team members\' unwavering commitment to meeting the needs of our patients, customers and communities. The role of the pharmacist and local pharmacy is now more vital than ever.”

GUIDANCE:

Company leadership to discuss strategic priorities for the future and fiscal 2022 guidance at Virtual Investor Conference today

Brewer added, “I look forward to sharing more about the future of WBA at our Virtual Investor Conference today.”

For earnings history and earnings-related data on Walgreens Boots Alliance (WBA) click here.